Information

Home Information
  • Feb 20, 2025

Oil Extends Gain With Focus on Supply Uncertainty, Weaker Dollar

(Bloomberg) -- Oil extended a string of marginal gains to settle above $72 a barrel amid uncertainty over global supplies and a slumping dollar that made commodities priced in the currency more attractive.Most Read from BloombergTrump to Halt NY Congestion Pricing by Terminating ApprovalAirbnb Billionaire Offers Pre-Fab Homes for LA Fire VictimsSorry, Kids: Disney’s New York Headquarters Is for Grown-UpsTrump Targets $128 Billion California High-Speed Rail ProjectChild Migrant Watchdog Gutted in

  • Feb 20, 2025

Fed's Barr, stepping down from regulatory post, warns against weaker bank rules

WASHINGTON (Reuters) -The Federal Reserve's top regulatory official cautioned Thursday against a weakening of bank rules and oversight that could make firms vulnerable to surprise shocks. Fed Vice Chair for Supervision Michael Barr, who is stepping down from the regulatory post at the end of February, cautioned against any push to significantly weaken existing bank rules and supervision, and urged watchdogs to complete international capital standards. In what is expected to be his final speech as the Fed's rules chief, Barr maintained that strong rules and robust capital requirements for banks are needed to guard against unforseen shocks.

  • Feb 20, 2025

US regulator withdraws appeal of rule on Treasury markets

U.S. Securities and Exchange Commission has decided to withdraw its appeal of a decision by a federal judge late last year to vacate an overhaul of Treasury dealer rules, according to a court document filed on Wednesday. In a statement, the SEC said it decided to dismiss the appeal because the new rule could reduce "liquidity in the Treasury markets, making them more volatile, and increasing debt for taxpayers." One year ago, the SEC under Chair Gary Gensler adopted a rule requiring proprietary traders and other firms that routinely deal in U.S. government bonds to register as broker-dealers, subjecting them to stricter oversight.

  • Feb 20, 2025

Market jitters over trade fade as investors call 'Tariff Man' Trump's bluff

The outsized swings in markets on the back of Donald Trump's every word on tariffs just weeks ago have faded to mere flickers, as investors switch their focus elsewhere, and bet against a full-scale trade war really materialising. China is one of the few trading partners on which Trump has increased tariffs, but Hong Kong's Hang Seng index is up 14% year to date, led by a surge in tech stocks. Similarly, traders are banking on less volatility in the Canadian dollar and Mexican peso - both slightly stronger than they were at the start of the year - and an index of European auto stocks - also vulnerable to tariffs - hit a seven-month high this week.

  • Feb 20, 2025

Fed’s Musalem Sees Increased Risk of Inflation Stalling Above 2%

(Bloomberg) -- Federal Reserve Bank of St. Louis President Alberto Musalem said policy should remain “modestly restrictive” until it’s clear inflation is on track to the central bank’s 2% target, and that he sees increased risks that progress may stall or even reverse. Most Read from BloombergTrump to Halt NY Congestion Pricing by Terminating ApprovalAirbnb Billionaire Offers Pre-Fab Homes for LA Fire VictimsSorry, Kids: Disney’s New York Headquarters Is for Grown-UpsTrump Targets $128 Billion C

  • Feb 20, 2025

Why Herbalife (HLF) Stock Is Up Today

Shares of health and wellness products company Herbalife (NYSE:HLF) jumped 44.6% in the afternoon session after the company reported impressive fourth-quarter results, which blew past analysts' EPS and EBITDA estimates. On the other hand, revenue guidance for the next quarter missed expectations, with sales projected to decline between 5.5% and 1.5% y/y. Full-year EBITDA guidance also fell short of Wall Street's estimates, raising concerns about the company's ability to sustain its margins and p

  • Feb 20, 2025

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 9.6% in the pre-market session after the company reported impressive fourth-quarter results, exceeding analysts' sales and EPS estimates. Total revenue grew 16% y/y fueled by strong demand for Voxzogo, which saw a 42% jump in sales, and a steady 9% increase in its Enzyme Therapies segment​. Improved profitability also played a key role, with GAAP net income soaring more than fivefold. Looking ahead, management expects another

  • Feb 20, 2025

Why ACV Auctions (ACVA) Stock Is Down Today

Shares of online used car auction platform ACV Auctions (NASDAQ:ACVA) fell 9.2% in the pre-market session after the company reported weak fourth-quarter results, and provided full-year revenue and EBITDA guidance below Wall Street's estimates. The outlook assumes a flat dealer wholesale market, which may limit upside potential in the near term. In addition, margins deteriorated and the company burned cash during the quarter. On the other hand, ACVA blew past analysts' EBITDA expectations this qu

Popular Post